Skip to main content

Table 4 Competing risk regression of factors associated with risks of cancer death, SA 1990–2010

From: Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians

Aboriginal – Yes SHR (95% CI)
Unadjusted 1.96 (1.71–2.24)
Baseline modela 1.60 (1.34–1.92)
PCSCI
 Baseline modela 1.60 (1.34–1.92)
 Adjusted for PCSCI 1.53 (1.28–1.83)
 Proportion explained by comorbidity for the effect of Aboriginality on survival 12%
CCI
 Baseline modela 1.60 (1.34–1.92)
 Baseline modela + CCI 1.54 (1.28–1.84)
 Proportion explained by comorbidity for the effect of Aboriginality on survival 10%
ECI
 Baseline modela 1.60 (1.34–1.92)
 Adjusted for ECI 1.57 (1.31–1.87)
 Proportion explained by comorbidity for the effect of Aboriginality on survival 5%
C3
 Baseline modela 1.60 (1.34–1.92)
 Adjusted for C3 1.54 (1.29–1.85)
 Proportion explained by comorbidity for the effect of Aboriginality on survival 10%
  1. Abbreviations: SHR Sub hazard ratio, CCI Charlson comorbidity index, WECI weighted Elixhauser comorbidity index, C3 cancer care and comorbidity index, PCSCI Population cancer specific comorbidity index
  2. aBaselines model adjusted for stage, remoteness area and SES